|
A more recent version of this article appeared on August 1, 2003
Papers In Press, published online ahead of print May 16, 2003
J. Lipid Res., doi:10.1194/jlr.M300097-JLR200
Submitted on February 28, 2003
Revised on May 7, 2003
Accepted on May 15, 2003
Apolipoprotein E genotype: specific inhibition of apoptosis
Robert M. DeKroon, Mirta Mihovilovic, Zoe V. Goodger, Jennifer B. Robinette, Patrick M. Sullivan, Ann M. Saunders, and Warren J. Strittmatter
Department of Medicine, Duke University Medical Center, Durham, NC 27710
Corresponding Author: warren{at}neuro.duke.edu
Endothelial cell apoptosis can be initiated by withdrawing growth factors or serum, and is inhibited by high-density lipoproteins (HDL). Our results show that the total lipoprotein population from apolipoprotein E 4/4 (APOE 4/4) sera is less anti-apoptotic than total lipoproteins from other APOE genotypes, as measured by caspase 3/7 activity. Moreover, APOE 4/4 very low-density lipoprotein (VLDL) antagonizes the anti-apoptotic activity of HDL, by a mechanism requiring binding of apoE4 on VLDL particles to an LDL-family receptor. This ability of APOE 4/4 VLDL to inhibit the anti-apoptotic effects of HDL presents a potential mechanism by which the expression of several diseases, including atherosclerosis, is enhanced by the APOE4 genotype.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
O. M. Kattan, F. B. Kasravi, E. L. Elford, M. T. Schell, and H. W. Harris
Apolipoprotein E-Mediated Immune Regulation in Sepsis
J. Immunol.,
July 15, 2008;
181(2):
1399 - 1408.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Mihovilovic, J. B. Robinette, R. M. DeKroon, P. M. Sullivan, and W. J. Strittmatter
High-fat/high-cholesterol diet promotes a S1P receptor-mediated antiapoptotic activity for VLDL
J. Lipid Res.,
April 1, 2007;
48(4):
806 - 815.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. DeKroon, J. B. Robinette, A. B. Hjelmeland, E. Wiggins, M. Blackwell, M. Mihovilovic, M. Fujii, J. York, J. Hart, C. Kontos, et al.
APOE4-VLDL Inhibits the HDL-Activated Phosphatidylinositol 3-Kinase/Akt Pathway via the Phosphoinositol Phosphatase SHIP2
Circ. Res.,
October 13, 2006;
99(8):
829 - 836.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Huang, P. C. Chen, and C. Poole
APOE-{epsilon}2 allele associated with higher prevalence of sporadic Parkinson disease
Neurology,
June 22, 2004;
62(12):
2198 - 2202.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Raber
Androgens, ApoE, and Alzheimer's Disease
Sci. Aging Knowl. Environ.,
March 17, 2004;
2004(11):
re2 - re2.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|